Breaking News Instant updates and real-time market news.

NCLH

Norwegian Cruise Line

$56.11

-0.03 (-0.05%)

18:33
03/19/19
03/19
18:33
03/19/19
18:33

Norwegian Cruise Line CEO: There is no recession

In an interview on CNBC's Mad Money, Norwegian Cruise Line CEO Frank Del Rio said: We have eleven ships on order between now and 2027... There's no recession and our ships run full all the time... Most investors have not been on a cruise ship... 25% of our business is millenials.

NCLH Norwegian Cruise Line
$56.11

-0.03 (-0.05%)

02/21/19
BUCK
02/21/19
NO CHANGE
Target $75
BUCK
Buy
Buckingham says backdrop 'sufficiently strong' for Norwegian to re-rate higher
Buckingham analyst Daniel McKenzie said investors might look at Norwegian Cruise Line's Q4 results "as not perfectly clean," but he believes the demand and revenue backdrop is "sufficiently strong enough to drive a higher re-rating of the stock." The company's 2019 guidance implies 7% EPS growth with "2020 looking quite strong as well," said McKenzie, who keeps a Buy rating and $75 price target on Norwegian shares.
02/25/19
MACQ
02/25/19
UPGRADE
MACQ
Outperform
Norwegian Cruise Line upgraded to Outperform from Neutral at Macquarie
02/25/19
02/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Norwegian Cruise Line (NCLH) upgraded to Outperform from Neutral at Macquarie. 2. Brunswick (BC) upgraded to Overweight from Neutral at JPMorgan by analyst Steven Zaccone, who said that following recent "encouraging" data points on the marine industry, macro backdrop, and company-specific growth drivers, the setup is more favorable to own Brunswick in 2019. 3. UGI Corporation (UGI) upgraded to Buy from Neutral at UBS by analyst Shneur Gershuni, who said the 8% selloff since mid-December is an overreaction to the company's recent Q1 miss on the back of warm weather. The analyst believes UGI's strategic review of AmeriGas (APU) could "substantially increase" the company's cash flow and market capitalization if a roll-up is the outcome.4. Infinera (INFN) upgraded to Neutral from Sell at MKM Partners by analyst Michael Genovese, who said the company's commentary about new bookings was better than he expected. Genovese also noted that management's view of significant backlog growth in Q4 and expectations for another increase in Q1, but warned that there is still "significant risk" to Infinera's 2019 revenue outlook being a "high hurdle." 5. Adidas (ADDYY) upgraded to Outperform from Market Perform at Wells Fargo by analyst Tom Nikic, who said his math suggests a greater-than-expected contribution from the long-awaited democratization of the Yeezy sub-brand. The company seems to have hit a ''lull'' on new product launches for the core brand and faces headwinds from the 2018 World Cup through Q2 of 2019, but Nikic believes these challenges are well understood by investors, and the ''opening the faucet'' on the Yeezy brand can get Adidas through these 2019 challenges and allow for a ''soft landing'' on the top line in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/19
MSCO
03/06/19
NO CHANGE
Target $54
MSCO
Equal Weight
Morgan Stanley cautious on Carnival ahead of Q1 report
Morgan Stanley analyst Jamie Rollo said the firm's qualitative survey of U.S. travel agents was somewhat more downbeat than last month while quantitative web research was mixed for Carnival (CCL) and positive for Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH). Rollo, who noted he has had a cautious view of the cruise industry for some time due to the significant amount of new capacity coming on-line, added that he is cautious on Carnival ahead of its quarterly report due in late March, stating that he sees limited room for an upgrade to its FY19 yield guidance given weakness at its European brands. He maintains Equal Weight ratings on Carnival and Royal Caribbean and an Overweight rating on Norwegian shares.

TODAY'S FREE FLY STORIES

XEC

Cimarex Energy

$68.58

-0.69 (-1.00%)

, REN

Resolute Energy

$0.00

(0.00%)

07:28
05/20/19
05/20
07:28
05/20/19
07:28
Upgrade
Cimarex Energy, Resolute Energy rating change  »

Cimarex Energy upgraded…

XEC

Cimarex Energy

$68.58

-0.69 (-1.00%)

REN

Resolute Energy

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 22

    May

DXC

DXC Technology

$56.32

-1.35 (-2.34%)

07:25
05/20/19
05/20
07:25
05/20/19
07:25
Recommendations
DXC Technology analyst commentary  »

DXC Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

REGN

Regeneron

$304.81

-4.69 (-1.52%)

07:24
05/20/19
05/20
07:24
05/20/19
07:24
Recommendations
Regeneron analyst commentary  »

Barclays still bearish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 14

    Jun

  • 26

    Jun

BYND

Beyond Meat

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Initiation
Beyond Meat initiated  »

Beyond Meat initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$147.06

-1.63 (-1.10%)

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Downgrade
Clorox rating change  »

Clorox downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:22
05/20/19
05/20
07:22
05/20/19
07:22
Downgrade
Bristol-Myers rating change  »

Bristol-Myers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 31

    May

SPN

Superior Energy

$2.49

-0.24 (-8.79%)

07:20
05/20/19
05/20
07:20
05/20/19
07:20
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

07:20
05/20/19
05/20
07:20
05/20/19
07:20
General news
FX Update: The dollar has put a mixed performance »

FX Update: The dollar has…

MTSC

MTS Systems

$56.33

-0.13 (-0.23%)

07:18
05/20/19
05/20
07:18
05/20/19
07:18
Recommendations
MTS Systems analyst commentary  »

MTS Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$7.39

-0.62 (-7.74%)

07:17
05/20/19
05/20
07:17
05/20/19
07:17
Hot Stocks
Akoustis announces shipments, production order for 3.8GHz filters »

Akoustis announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.80

0.02 (0.05%)

07:16
05/20/19
05/20
07:16
05/20/19
07:16
Hot Stocks
AstraZeneca reports data from Novel START trial of Symbicort »

New data from Novel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

DE

Deere

$134.82

-11.15 (-7.64%)

07:15
05/20/19
05/20
07:15
05/20/19
07:15
Recommendations
Deere analyst commentary  »

Deere price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

07:13
05/20/19
05/20
07:13
05/20/19
07:13
Hot Stocks
PDC Energy CEO sends letter to shareholders, encourages white proxy card vote »

PDC Energy mailed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

HEI

Heico

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Heico analyst commentary  »

Heico price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 05

    Jun

MU

Micron

$36.06

-1.37 (-3.66%)

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CLI

Mack-Cali Realty

$22.92

-0.12 (-0.52%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Hot Stocks
Mack-Cali Realty recommends stockholders vote the WHITE proxy card »

Mack-Cali strongly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

07:10
05/20/19
05/20
07:10
05/20/19
07:10
General news
Oil prices down from highs over USD 63 »

Oil prices down from…

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TSLA

Tesla

$211.02

-17.56 (-7.68%)

07:09
05/20/19
05/20
07:09
05/20/19
07:09
Recommendations
Tesla analyst commentary  »

Tesla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

, MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

07:08
05/20/19
05/20
07:08
05/20/19
07:08
Recommendations
Alnylam, The Medicines Co. analyst commentary  »

Alnylam partner presented…

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Earnings
SpartanNash reaffirms FY19 adjusted EPS view $1.20-$1.50, consensus $1.69 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

CGEN

Compugen

$3.45

0.01 (0.29%)

, BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Hot Stocks
Compugen doses first patient in Phase 1 COM701/Opdivo study »

Compugen (CGEN) announced…

CGEN

Compugen

$3.45

0.01 (0.29%)

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 29

    May

  • 31

    May

TRK

Speedway Motorsports

$18.14

-0.035 (-0.19%)

07:06
05/20/19
05/20
07:06
05/20/19
07:06
Hot Stocks
Speedway Motorsports retains advisor to consider going private proposal »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$104.76

-2.98 (-2.77%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Recommendations
Xilinx analyst commentary at Nomura Instinet »

U.S. action against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.29

-0.07 (-1.31%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Hot Stocks
Intec Pharma granted European patent »

Intec Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.